Direkt zum Inhalt
Merck
  • Hematogenous macrophage depletion reduces the fibrotic scar and increases axonal growth after spinal cord injury.

Hematogenous macrophage depletion reduces the fibrotic scar and increases axonal growth after spinal cord injury.

Neurobiology of disease (2014-12-03)
Y Zhu, C Soderblom, V Krishnan, J Ashbaugh, J R Bethea, J K Lee
ZUSAMMENFASSUNG

Spinal cord injury (SCI) leads to formation of a fibrotic scar that is inhibitory to axon regeneration. Recent evidence indicates that the fibrotic scar is formed by perivascular fibroblasts, but the mechanism by which they are recruited to the injury site is unknown. Using bone marrow transplantation in mouse model of spinal cord injury, we show that fibroblasts in the fibrotic scar are associated with hematogenous macrophages rather than microglia, which are limited to the surrounding astroglial scar. Depletion of hematogenous macrophages results in reduced fibroblast density and basal lamina formation that is associated with increased axonal growth in the fibrotic scar. Cytokine gene expression analysis after macrophage depletion indicates that decreased Tnfsf8, Tnfsf13 (tumor necrosis factor superfamily members) and increased BMP1-7 (bone morphogenetic proteins) expression may serve as anti-fibrotic mechanisms. Our study demonstrates that hematogenous macrophages are necessary for fibrotic scar formation and macrophage depletion results in changes in multiple cytokines that make the injury site less fibrotic and more conducive to axonal growth.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Dimethylsulfoxid, Hybri-Max, sterile-filtered, BioReagent, suitable for hybridoma, ≥99.7%
Sigma-Aldrich
Tetrahydrofuran, inhibitor-free, suitable for HPLC, ≥99.9%
Sigma-Aldrich
Dimethylsulfoxid, ACS reagent, ≥99.9%
Sigma-Aldrich
Dimethylsulfoxid, Molecular Biology
Sigma-Aldrich
Dimethylsulfoxid, suitable for HPLC, ≥99.7%
Sigma-Aldrich
Dimethylsulfoxid, sterile-filtered, BioPerformance Certified, meets EP, USP testing specifications, suitable for hybridoma
Sigma-Aldrich
Dimethylsulfoxid, ReagentPlus®, ≥99.5%
Sigma-Aldrich
Tetrahydrofuran, contains 200-400 ppm BHT as inhibitor, ACS reagent, ≥99.0%
Sigma-Aldrich
Dimethylsulfoxid, anhydrous, ≥99.9%
Sigma-Aldrich
Tetrahydrofuran, anhydrous, ≥99.9%, inhibitor-free
Sigma-Aldrich
Tetrahydrofuran, anhydrous, contains 250 ppm BHT as inhibitor, ≥99.9%
Sigma-Aldrich
Dimethylsulfoxid, ≥99.5% (GC), suitable for plant cell culture
Sigma-Aldrich
DAPI, for nucleic acid staining
Sigma-Aldrich
Dimethylsulfoxid, puriss. p.a., ACS reagent, ≥99.9% (GC)
Sigma-Aldrich
Benzylalkohol, ReagentPlus®, ≥99%
Sigma-Aldrich
Benzylalkohol, ACS reagent, ≥99.0%
Supelco
Benzylalkohol, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
Anti-Laminin in Kaninchen hergestellte Antikörper, 0.5 mg/mL, affinity isolated antibody, buffered aqueous solution
Sigma-Aldrich
Dimethylsulfoxid, BioUltra, Molecular Biology, ≥99.5% (GC)
Sigma-Aldrich
Tetrahydrofuran, ≥99.0%, contains 200-400 ppm BHT as inhibitor, ReagentPlus®
USP
Benzylalkohol, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
Tetrahydrofuran, contains 250 ppm BHT as inhibitor, puriss. p.a., ACS reagent, reag. Ph. Eur., ≥99.9%
Sigma-Aldrich
Benzylalkohol, puriss., meets analytical specification of Ph. Eur., BP, NF, 99-100.5% (GC)
Sigma-Aldrich
Dimethylsulfoxid, meets EP testing specifications, meets USP testing specifications
Sigma-Aldrich
Benzylalkohol, anhydrous, 99.8%
Sigma-Aldrich
Tetrahydrofuran, ACS reagent, ≥99.0%, contains 200-400 ppm BHT as inhibitor
Sigma-Aldrich
Dimethylsulfoxid, PCR Reagent
Sigma-Aldrich
Benzylalkohol, puriss. p.a., ACS reagent, ≥99.0% (GC)
Sigma-Aldrich
Benzylbenzoat, ReagentPlus®, ≥99.0%
Sigma-Aldrich
Dimethylsulfoxid, puriss. p.a., dried, ≤0.02% water